Tumour cell detection in the bone marrow of breast cancer patients at primary therapy: results of a 3-year median follow-up.

por Harbeck, N., Untch, M., Pache, L., Eiermann, W.
Publicado 1994

Prognostic impact of proliferation-associated factors MIB1 (Ki-67) and S-phase in node-negative breast cancer.

por Dettmar, P., Harbeck, N., Thomssen, C., Pache, L., Ziffer, P., Fizi, K., Jänicke, F., Nathrath, W., Schmitt, M., Graeff, H., Höfler, H.
Publicado 1997

Prognostic significance of urokinase (uPA) and its inhibitor PAI-1 for survival in advanced ovarian carcinoma stage FIGO IIIc

por Kuhn, W, Schmalfeldt, B, Reuning, U, Pache, L, Berger, U, Ulm, K, Harbeck, N, Späthe, K, Dettmar, P, Höfler, H, Jänicke, F, Schmitt, M, Graeff, H
Publicado 1999